Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg
Condition: Type2 Diabetes Intervention: Drug: Evogliptin, Glimepiride, Evogliptin + Glimepiride Sponsor: Dong-A ST Co., Ltd. Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2016 Category: Research Source Type: clinical trials
Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
Condition: Type2 Diabetes Mellitus Interventions: Drug: Bexagliflozin; Drug: Metformin; Drug: Glimepiride; Drug: Sitagliptin Sponsor: Theracos Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2016 Category: Research Source Type: clinical trials
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg
Condition: Type2 Diabetes Interventions: Drug: Evogliptin→Evogliptin+Glimepiride→Glimepiride; Drug: Glimepiride→Evogliptin→Evogliptin+Glimepiride Sponsor: Dong-A ST Co., Ltd. Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2016 Category: Research Source Type: clinical trials
Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
Condition: Type2 Diabetes Mellitus Interventions: Drug: Bexagliflozin; Drug: Metformin; Drug: Glimepiride; Drug: Sitagliptin Sponsor: Theracos Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2016 Category: Research Source Type: clinical trials